We are Sorry, This Page doesn't Exist
Gilead Sciences reports positive data in trial of remdesivir as treatment for COVID-19
Gilead Sciences Inc. said that its experimental COVID-19 therapy remdesivir met the main goal in a government-funded clinical trial and that a shorter dosing regimen was as successful as a longer one in a separate study......»»
Corbus expects safety data from Phase 1 study of CRB-4001 in 2020
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Provention Bio reports "positive" data from Phase 1b PREVAIL study of PRV-3279
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Avadel Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results
Completed enrollment for the pivotal REST-ON Phase 3 study in Q4 2019; data readout expected in Q2 2020 Raised $65 million in gross proceeds from privat.....»»
Kodiak Sciences study data align with bullish expectations, says Roth Capital
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Moderna reports "positive" safety, immunogenicity data from CMV vaccine study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Xeris Pharmaceuticals reports "positive" phase 2 data in glucagon study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Agios Pharmaceuticals reports new data from DRIVE PK Phase 2 study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Achillion reports "positive" data from Phase 2 danicopan, eculizumab study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Alpine Immune Sciences presents ALPN-101 Phase 1 healthy volunteer study data
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
TG Therapeutics reports triple therapy data from Phase I/II study of ublitux
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Alnylam initiates Phase 3 study of lumasiran, reports "positive" Phase 2 data
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Immutep reports efficacy data for TACTI-mel Phase 1 clinical study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Aravive reports data from Phase 1b/2 study of AVB-500 in ovarian cancer
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Cassava Sciences reports results from Phase 2a clinical study of PTI-125
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Xynomic reports interim data from Phase 1b study of abexinostat w/ Keytruda
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Vaccinex Reports Second Quarter 2019 Financial Results and Provides Corporate Update
Completed enrollment of the dose expansion cohort in the Phase 1b/2 CLASSICAL-Lung study in non-small cell lung cancer; primary completion expected in the second half of 2019 Presented interim data from CLASSICAL-Lung study.....»»
Deciphera reports updated data from Phase 1 ripretinib study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Applied Therapeutics reports AT-007 SAD data from Phase 1/2 study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Hemispherx reports "positive" data in Phase 1 study using Ampligen
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»